Cargando…
Infliximab-Induced Acute Liver Failure in a Patient With Crohn's Disease Requiring Orthotopic Liver Transplantation
Tumor necrosis factor-alpha inhibitors are not known to have significant liver toxicity; however, a few case reports state otherwise. We report the case of a 25-year-old man with Crohn's disease who was initiated on infliximab. The patient developed severe mixed hepatocellular and cholestatic l...
Autores principales: | Mustafa Alikhan, Muhammed, Mansoor, Emad, Satyavada, Sagarika, Greer, Katarina, Xin, Wei, Cohen, Stanley, Cooper, Gregory, Katz, Jeffry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126550/ https://www.ncbi.nlm.nih.gov/pubmed/34007859 http://dx.doi.org/10.14309/crj.0000000000000586 |
Ejemplares similares
-
Post–Liver Transplant Lymphoproliferative Disorder Presenting as Biliary Stricture
por: Karb, Daniel, et al.
Publicado: (2021) -
Infliximab‐induced autoimmune hepatitis requiring liver transplantation
por: Wong, Frederick, et al.
Publicado: (2019) -
Multiple liver abscesses in Crohn’s disease in infliximab therapy, successfully treated with antibiotic therapy
por: Otheo, Enrique, et al.
Publicado: (2019) -
Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007) -
Letter to the Editor: Characteristics of Liver Transplant Patients Admitted with COVID-19
por: Mansoor, Emad, et al.
Publicado: (2021)